Wantai COVID-19 Diagnostic Kits
Best performing COVID kits as recommended by WHO*
-
COVID-19 Total Ab ELISA
-
COVID-19 IgM ELISA
-
COVID-19 Total Ab Rapid kit
COVID-19 diagnostic facts and figures
COVID-19 serological markers dynamics (Total Ab/ IgM/ IgG)
20%-40% of the patients developed antibodies on days 0-7 after onset
60%~70% of the patients developed antibodies on days 8-11 after onset
> 90% of the patients had detectable levels of antibodies starting from day 12 after onset.
COVID-19 molecular markers dynamics (RNA)
RNA was detected in 60-75% of the patients on days 0-8 after onset
RNA levels decrease to 40-50% starting from day 9 after onset
COVID-19 combined serological and molecular markers increases the sensitivity of
diagnosis while maintaining the high specificity. Among the serological markers, total Ab detection has greater significance in clinical practice.
Serological and virological markers of COVID-19
Antibody testing is being considered as one of the options in the current pandemic COVID – 19. RTPCR remains the gold standard however, antibody testing can be of importance in contact tracing for surveillance and epidemiological studies.
WANTAI COVID-19 Total Antibody ELISA
Fast Results Results within 75 minutes
Antigen coating S1 RBD recombined antigens for maximum specificity
Total antibody detection IgG+ IgM detection thus providing better screening tool with enhanced sensitivity
Sample Type Serum/Plasma
Controls 2 level controls viz. Positive and negative controls provided
Cost efficient Breakaway microwells for ease of use
Quality Approved CE marked and IVD approved
Excellent performance
PPV: 100%
NPV: 95.33%
Sensitivity: 94.36%
Specificity: 100.00%
Overall agreement: 97.38%
WANTAI COVID-19 IgM ELISA
Assay principle Mu capture for better sensitivity and specificity avoiding any cross reactions.
Fast Results Results within 75 minutes
Antigen coating S1 RBD recombined antigens for maximum specificity
Total antibody detection IgG+ IgM detection thus providing better screening tool with enhanced sensitivity
Sample Type Serum/Plasma
Controls 2 level controls viz. Positive and negative controls provided
Cost efficient Breakaway microwells for ease of use
Quality Approved CE marked and IVD approved
Excellent performance
Sensitivity: 86.09%
Specificity: 99.35%
Overall agreement: 93.18%
Related Products
Chemiluminescence Immunoassay
Fully Automated Nephelometry
Automated Critical Care Immunoassay Analyser
Seegene COVID-19 RT PCR
